CYPH
NASDAQ
$0.72
Cypherpunk Technologies Inc (CYPH)
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.
Sector:
Financial Services
Industry:
Asset Management
Target: $0.90 (+25.54%)
Market Cap
$71M
P/B Ratio
0.92
Free Cash Flow Yield
-46.48%
Beta (5Y)
2.16
Price Chart
Valuation
Market Cap$71M
P/S160.10
P/B0.92
Profitability
EBITDA-$108M
EPS-$0.82
Financial Health
Free Cash Flow Yield-46.48%
Growth & Risk
EPS 5Y CAGR+10.80%
FCF 5Y CAGR+1.42%
Beta (5Y)2.16
Sharpe Ratio1.07